We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bristol-Myers Squibb To Pay $19.5M Over Abilify Marketing

Law360, New York (December 8, 2016, 5:08 PM EST) -- Bristol-Myers Squibb will pay $19.5 million to 42 states and Washington, D.C., to settle claims that the company allegedly improperly marketed the antipsychotic drug Abilify, multiple states’ attorneys general announced Wednesday....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.